Genetic aberrations in oral or head and neck squamous cell carcinoma. 2: Chromosomal aberrations

Oral Oncology

Volumn 36, Issue 4, 2000, Pages 311-327

  Scully, C ^a   Field, J K ^b,c   Tanzawa, H ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c Roy Castle International Centre for Lung Cancer Research   (United Kingdom)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

Cancer; Chromosomes; Genetics; Oral

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME ABERRATION; DNA REPAIR; GENE EXPRESSION; GENE MUTATION; HEAD AND NECK CANCER; HETEROZYGOSITY LOSS; HUMAN; MOUTH CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; GENES, P53; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; TELOMERASE;

EID: 0033933721     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(00)00021-X     Document Type: Article

References (288)

1. Scully C, Field J, Tanazawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncology 2000;36:256-263.
2. Stich H.F. Micronucleated exfoliated cells as indicators for genotoxic damage and as markers in chemoprevention trials. J Nutr Growth Cancer. 4:1987;9-18.
3. Scully C., Field J.K. Genetic aberrations in squamous cell carcinoma of the head and neck (SCCHN), with reference to oral carcinoma (Review). Int J Oncol. 10:1997;5-21.
4. Oh Y., Mao L. Biomarkers in head and neck carcinoma. Curr Opin Oncol. 9:1997;247-256.
5. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science. 278:1997;1054-1059.
6. Yamamoto K., Konishi N., Inui T., Nakamura M., Hiasa Y., Kirita T.etal. DNA alterations in human oral squamous cell carcinomas detected by restriction landmark genomic scanning. J Oral Pathol Med. 28:1999;102-106.
7. Ishwad C.S., Ferrell R.E., Rossie K.M, Appel B.N., Johnson J.T., Myers E.Netal. Microsatellite instability in oral cancer. Int J Cancer. 64:1995;332-335.
8. Lee J.S., Kim S.Y., Hong W.K., Lippmann S.M., Ro J.Y., Gay M.L.etal. Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesions. J Natl Cancer Inst. 85:1993;1951-1954.
9. Hermsen M.A.J.A., Joenje H., Arwert F., Braakhuis B.J.M., Baak J.P.A., Westerveld A.etal Asssessment of chromosomal gains and losses in oral squamous cell carcinoma by comparative genomic hybridisation. Oral Oncology. 33:1997;414-418.
10. Wolff E., Girod S., Liehr T., Vorderwulbecke U., Ries J., Steininger H.etal. Oral squamous cell carcinomas are characterised by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridisation. Oral Oncology. 34:1998;186-190.
11. Takes R.P., Baatenburg de Jong R.J., Schuuring E., Litvinov S.V., Hermans J., Van Krieken J.H.J.M. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell. Anticancer Res. 18:1998;4793-4800.
12. Scully C. Oncogenes, tumor suppressors and viruses in oral squamous cell carcinoma. J Oral Pathol Med. 22:1993;337-347.
13. Partridge M., Emilion G., Pateromichelakis S., Phillips E., Langdon J. Field cancerisation of the oral cavity. comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions Oral Oncology. 33:1997;332-337.
14. Emilion G., Langdon J.D., Speight P., Partridge M. Frequent gene deletions in potentialy malignant oral lesions. Br J Cancer. 73:1996;809-813.
15. Mao L., Lee J.S., Fan Y.H., Ro J.Y., Batsakis J.G., Lippman S.etal. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nature Medicine. 2:1996;682-685.
16. Roz L., Wu C.L., Porter S.R., Scully C., Speight P., Read A.etal. Allelic imbalance on chromosome 3p in oral dysplastic lesions. an early event in oral carcinogenesis Cancer Res. 56:1996;1228-1231.
17. Maestro R., Gasparotto D., Vukosavljevic T., Barzan L., Sulfaro S., Boiocchi M. Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res. 53:1993;5779-5885.
18. Field J.K., Tsiriyotis C., Zoumpourlis V., Howard P., Spandidos D.A., Jones A.S. Allele loss on chromosome 3 in squamous cell carcinoma of the head and neck correlates with poor clinical prognostic indicators. International Journal of Oncology. 4:1994;543-549.
19. Partridge M., Kiguwa S., Langdon J.D. Frequent deletion of chromosome 3p in oral squamous cell carcinoma. Oral Oncol, Eur J Cancer. 30B:1994;248-251.
20. Ah-See, Cooke TG, Pickford IR, Soutar D, Balmain A. Allelotype of squamous carcinoma of the head and neck using microsatellite. Cancer Research 1994;54:1617-21.
21. Mao L. Leukoplakia: molecular understanding of pre-malignant lesions and implications for clinical management. Mol Med Today 1997 Oct;3(10):442-8.
22. Field JK. The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma. J R Soc Med 1995;88:35P-9P.
23. Ishwad C.S., Ferrell R.E., Rossie K.M., Appel B.N., Johnson J.T., Myers E.Netal. Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancer. Int J Cancer. 69:1996;1-4.
24. Lydiatt W.M., Davidson B.J., Schantz S., Caruana S., Chaganti R.S.K. 9p21 deletion correlates with recurrence in head and neck cancer. Head Neck. 20:1998;113-118.
25. Venugopolan M., Wood T.F., Wilczynski S.P., Sen S., Peters J., Ma G.C.etal. Loss of heterozyosity in squamous cell carcinomas of the head and neck defines a tumour suppressor gene region on 11q13. Cancer Genet Cytogenet. 104:1998;124-132.
26. Wu C.-L., Sloan P., Read A.P., Harris R., Thakker N. Deletion mapping on the short arm chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res. 54:1994;6484-6488.
27. Califano J., Van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S.etal. Genetic progression model for head and neck cancer; implications for field cancerization. Cancer Res. 56:1996;2488-2492.
28. Virgilio L., Schuster M., Gollin S.M.etal. FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci. 93:1996;9770-9775.
29. Kisielewski A.E., Xiao G.H., Liu S.C., Klein-Szanto A.J.P., Novara M., Sina J.etal. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck. Oncogene. 17:1998;83-91.
30. Gonzalez M.V., Pello M.F., Ablanedo P., Suarez C., Alvarez V., Coto E. Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and β-cat genes in squamous cell carcinoma of the head and neck. J Clin Pathol. 51:1998;520-524.
31. Uzawa N., Yoshida M.A., Hosoe S., Oshimura M., Amagasa T., Ikeuchi T. Functional evidence for involvement of multiple tumour suppressor genes on the short arm of chromosome 3 in human oral squamous cell carcinogenesis. Cancer Genet Cytogenet. 107:1998;125-131.
32. Shriver S.P., Shriver M.D., Tirpak D.L., Bloch L.M., Hunt J.D., Ferrell R.E.et al. Trinucleotide repeat length variation in the human ribosomal protein L14 gene (RPL14). localisation to 3p213 and loss of heterozygosity in lung and oral cancers Mutat Res. 406:1998;9-23.
33. Shridar R., Shridar V., Rivard S., Siegfried J.M., Pietraszkiewicz H., Ensley J.et al. Mutations in the arginine-rich protein gene in lung, breast, and prostate cancers, and in squamous cell carcinomas of the head and neck. Cancer Res. 56:1996;5576-5578.
34. Garrigue-Antar L., Munoz-Antonia T., Antonia S.J., Gesmonde J., Velluci V.F., Reiss M. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res. 55:1995;3982-3987.
35. Eisma R.J., Spiro J.D., von Biberstein S.E., Lindquist R., Kreutzer D.L. Decreased expression of TGF receptors on head and neck SqCC tumor cells. Am J Surg. 172:1996;641-645.
36. Partridge M., Emilion G., Pateromichelakis S., Phillips E., Langdon J. Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p, and 9p for oral squamous cell carcinomas. Int J Cancer. 83:1999;318-325.
37. Waber P.G., Lee N.K., Nisen P.D. Frequent allelic loss at chromosome are 3p is distinct from genetic alteration of the von-Hippel Lindau tumour suppressor gene in head and neck cancer. Oncogene. 12:1996;365-369.
38. Uzawa K., Suzuki H., Yokoe H., Tanzawa H., Sato K. Mutational state of p16/CDKN2 and VHL genes in squamous cell carcinoma of the oral cavity. Int J Oncol. 7:1995;895-899.
39. Pershouse MA, El-Naggar AK, Hurr K, Lin H, Yung WK, Steck PA. Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene 1997 Jan 23;14:369-373.
40. Wang X.L., Uzawa K., Imai F.L., Tanzawa H. Localisation of a nover tumour suppressor gene associated with human oral cancer on chromosome 4q25. Oncogene. 18:1999;823-825.
41. Largey J.S., Meltzer S.J., Sauk J.J., Hebert C.A., Archibald D.W. Loss of heterozygosity involving the APC gene in oral squamous cell carcinomas. Oral Surg, Oral Med, Oral Path. 77:1994;260-263.
42. Uzawa K., Yoshida H., Susuki H., Tanzawa H., Shimazaki J., Senio S.etal. Abnormalities of the adenomatous polyposis coli gene in human oral squamous cell carcinolma. Int J Cancer. 58:1994;814-817.
43. Wang X.L., Uzawa K., Nakanishi H., Tanzawa H., Sato T. Allelic imbalance on the long arm of chromosome 5 in oral squamous cell carcinoma. Int J Oncol. 10:1997;535-538.
44. Huang J.S., Chiang C.P., Kok S.H., Kuo Y.S., Kuo M.Y.P. Loss of heterozygosity of APC and MCC genes in oral squamous cell carcinomas in Taiwan. J Oral Pathol Med. 26:1997;322-326.
45. Mao E.J., Schwartz S.M., Daling J.R., Beckmann A.M. Loss of heterozygosity at 5q21-22 (adenomatous polyposis coli gene region) in oral squamous cell carcinoma is common and correlated with advanced disease. J Oral Pathol Med. 27:1998;297-302.
46. Martins C., Jin Y., Jin C., Wennerberg J., Hoglund M., Mertens F. Fluorescent in situ hybridisation (FISH) characterisarion of pericentromeric breakpoints on chromosome 5 in head and neck squamous cell carcinomas. Eur J Cancer. 35:1999;498-501.
47. Imai F.L., Uzawa K., Shiiba M., Watanabe T., Miya T., Kubosawa H.etal Evidence of multi-step oncogenesis of oral squamous cell carcinoma. Oncology Reports. 5:1998;1489-1491.
48. Nawroz H., van der Riet P., Hruban R.H., Koch W., Ruppert J.M., Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Research. 54:1994;1152-1155.
49. Mathias C., Bockmuhl U., Jahnke V., Harries L.W., Wolf C.R., Jones P.W.etal. The glutathione S-transferase GSTP1 polymorphism. effects on susceptibility to oral/pharyngeal and laryngeal carcinomas Pharmacogenetics. 8:1998;1-6.
50. WAF1. Oral Oncology. 36:1999;3-7.
51. Heinzel P.A., Balaram P., Berbard H.U. Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers. Int J Cancer. 68:1997;420-423.
52. Erber R., Klein W., Enders C., Born A.I., Conradt C., Bartek Jetal Aberrant p21 protein accumulation in head-and-neck cancer. Int J Cancer. 74:1997;383-389.
53. Van Oijen M.G.C.T., Tilanus M.G.J., Medema R.H., Slootweg P.J. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol. 27:1998;367-375.
54. Warnakulasuriya K.A.A.S., Tavassoli M., Johnson N.W. Relationship of p53 overexpression to other cell cycle regulatory proteins in oral squamous cell carcinoma. J Oral Pathol Med. 27:1998;376-381.
55. Kudo Y., Takata T., Ogawa I., Sato S., Nikai H. Expression of p53 and p21CIP1/WAF1 proteins in oral epithelial dysplasia and squamous cell carcinomas. Oncol Rep. 6:1999;539-545.
56. Agarwal S., Mathur M., Shukla N.K., Ralhan R. Expression of cyclin-dependent kinase inhibitor p21 waf1/cip1 in premalignant and malignant oral lesions; relationship with p53 status. Oral Oncology. 34:1998;353-360.
57. Yook J.I., Kim J. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Oral Oncology. 34:1998;198-203.
58. Voravud N., Shin D.M., Ro J.Y., Lee J.S., Hong W.K., Hittelman W.N. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Research. 53:1993;2874-2883.
59. Rubin Grandis J., Chakraborty A., Melhem M.F., Zeng Q., Tweardy D.J. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. Oncogene. 15:1997;409-416.
60. Maiorano E., Favia G., Maisonneuve P., Viale G. Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa. J Pathol. 185:1998;167-174.
61. Ibrahim S.O., Lillehaug J.R., Johannessen A.C., Liavaag P.G., Nilsen R., Vasstrand E.N. Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas. Oral Oncology. 35:1999;302-313.
62. Shin D.M., Ro J.Y., Hong W.K., Hittelman W.N. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Research. 54:1994;3153-3159.
63. Rubin Grandis J., Tweardy D.J., Melhem M.F. Asynchronous modulation of transforming growth factor-α and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma. Clin Cancer Res. 4:1998;13-20.
64. Grandis J.R., Tweardy D.J. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res. 53:1993;3579-3584.
65. Kunikata M., Yamada K., Yamada T., Mori M., Tatemoto Y., Osaki T. Epidermal growth factor receptor in squamous cell carcinoma and other epidermal lesions of squamous origin. an immunohistochemical study Acta Histochem Cytochem. 25:1992;387-394.
66. Sakai H., Kawano K., Okamura K., Hashimoto N. Immunohistochemical localization of c-myc and EGF receptor gene products in oral squamous cell carcinoma. J Oral Pathol Med. 19:1990;1-4.
67. Todd R., Donoff B.R., Gertz R., Chang A.L., Chow P., Matossian K.etal. TGF-α and EGF receptor mRNAs in human oral cancers. Carcinogenesis. 10:1989;1553-1556.
68. Shirasuna K., Hayashido Y., Sugiyama M., Yoshioka H., Matsuya T. Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy. Virchows Arch (A). 418:1991;349-353.
69. Kuttan N.A.A., Zhang L., Rosin M.P., Bhakthan N.M.G., Priddy R.W. The value of epidermal growth factor receptor (EGFR) as a tumour marker for human oral premalignant and malignant lesions. International Journal of Oncology. 5:1994;955-960.
70. Kusukawa J., Harada H., Shima I., Sasaguri Y., Kameyama T., Morimatsu M. The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity. Eur J Cancer B Oral Oncol. 32B(4):1996;217-221.
71. Wang X.L., Uzawa K., Miyakawa A., Shiba M., Watanabe T., Sato T.etal. Localisation of a tumour suppressor gene associated with human oral cancer on 7q31. 1. Int J Cancer. 75:1998;671-674.
72. Patel V., Yeudall W.A., Gardner S., Mutlu S., Scully C., Prime S.S. Consistent chromosomal anomalies in keratinocyte cell lines derived from untreated malignant lesions of the oral cavity. Genes, Chromosomes and Cancer. 7:1993;109-115.
73. Wu C.L., Roz L., Sloan P., Read A.P., Holland S., Porter S.R.etal Deletion mapping defines three discrete areas of allelic imbalance on chromosome 8p in oral and oropharyngeal squamous cell carcinomas. Genes, Chromosomes and Cancer. 20:1997;347-353.
74. El-Naggar A.K., Coombes M.M., Batsakis J.G., Hong W.K., Goepfert H., Kagan J. Localisation of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma. Oncogene. 16:1998;2983-2987.
75. Ishwad C.S., Shuster M., Bockmuhl U., Thakker N., Shah P., Toomes C.etal Frequent allelic loss and homozygous deletion in chromosome band 8p23 in oral cancer. Int J Cancer. 80:1999;25-31.
76. Ono K., Miyakawa A., Fukuda M., Shiiba M., Uzawa K., Watanabe T.etal. Allelic loss on the short arm of chromosome 8 in oral squamous cell carcinoma. Oncol. Rep. 6:1999;785-789.
77. Sunwoo J.B., Sun P.C., Gupta V.K., Schmidt A.P., El-Mofty S., Scholnick S.B. Localization of a putative tumor suppressor gene in the sub-telomeric region of chromosome 8p. Oncogene. 18:1999;2651-2655.
78. Eversole L.R., Sapp J.P. c-myc oncoprotein expression in oral precancerous and early cancerous lesions. Oral Oncol, Eur J Cancer. 29B:1993;131-135.
79. Tadokoro K., Ueda M., Ohshima T., Fujita K., Rikimaru K., Takashashi N.etal. Activation of oncogenes in human oral cancer cells:a novel codon 13 mutation of c-Ha-ras-1 and concurrent amplifications of c-erbB-1 and c-myc. Oncogene. 4:1989;499-505.
80. Riviere A., Wilckens C., Loning T. Expression of c-erbB2 and c-myc in squamous epithelia and squamous cell carcinomas of the head and neck and the lower female genital tract. J Oral Pathol Med. 19:1990;408-413.
81. Leonard J.H., Kearsley J.H., Chenevix-Trench G., Hayward N.K. Analysis of gene amplification in head and neck squamous cell carcinomas. Int J Cancer. 48:1991;511-515.
82. Rodrigo J.P., Lazo P.S., Ramos S., Alvares I., Suarez C. MYC amplification in squamous cell carcinomas of the head and neck. Arch Otolaryngol Head Neck Surg. 122:1996;504-507.
83. Muller D., Millon R., Lidereau R., Engelmann A., Bronner G., Flesch H.etal. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur J Cancer B Oral Oncol. 30B(2):1994;113-120.
84. Miracca E.C., Kowalski L.P., Nagai M.A. High prevalence of p16 genetic alterations in head and neck tumours. Brit J Cancer. 81:1999;677-683.
85. Van der Reit P., Nawroz H., Hruban R.H., Corio R., Tokino K., Kochet al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 54:1994;1156-1158.
86. El-Naggar A.K., Hurr K., Batsakis J.G., Luna M.A., Goepfert H., Huff V. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res. 55:1995;2656-2659.
87. Lydiatt W.M., Davidson B.J., Shah J., Schantz S.P., Chaganti R.S.K. The relationship of loss of heterozygosity to tobacco exposure and early recurrence in head and neck squamous-cell carcinoma. Am J Surg. 168:1994;437-440.
88. Nakanishi H., Wang X.L., Imai F.L., Kato J., Shiiba M., Miya T.etal. Localisation of a novel tumour suppressor gene loci on chromosome 9p21-22 in oral cancer. Anticancer Res. 19:1999;29-34.
89. Zhao Y., Zhang S., Fu B., Xiao C. Abnormalities of tumor suppressor genes p16 and p15 in primary maxillofacial squamous cell carcinomas. Cancer Genet Cytogenet. 112:1999;26-33.
90. Pande P., Mathur M., Shukla N.K., Ralhan R. pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncology. 34:1998;396-403.
91. Papadimitrakopoulou V., Izzo J., Lippman S.M., Lee J.S., Fan Y.H., Clayman G.etal. Frequent inactivation of p16(INK4a) in oral premalignant lesions. Oncogene. 14:1997;1799-1803.
92. Chen Q.M., Luo G., Li B.Q., Samaranayake L.P. Expression of p16 and CDK4 in oral premalignant lesions and oral squamous cell carcinomas. a semi-quantitative immunohistochemical study J Oral Pathol Med. 28:1999;158-164.
93. Cairns P. Rates of p16 (MTS1) mutations in primary tumours with 9p loss. Science. 265:1994;415-416.
94. Zhang S.-Y., Klein-Szanto A.J.P., Sauter E.R., Shafarenko M., Mitsunga S., Nobori T.etal. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res. 54:1994;5050-5053.
95. Gonzalez M.V., Pello M.F., Lopez Larrea C., Suarez C., Menendez M.J., Coto E. Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and necl squamous cell carcinoma. J Clin Pathol. 50:1997;509-512.
96. Nakanishi H., Uzawa K., Yokoe H.etal Rare mutations of the growth suppressor genes involved in negative regulation of the cell cycle. p15, p16 and p18 genes in oral squamous cell carcinoma Int J Oncol. 11:1997;1129-1133.
97. Olshan A.F., Weissler M.C., Pei H., Conway K., Anderson S., Fried D.B.etal Alterations of the p16 gene in head and neck cancer. frequency and association with p53, PRAD-1 and HPV Oncogene. 14:1997;811-818.
98. Riese U., Dahse R., Fiedler W., Theuer C., Koscielny S., Ernstet al. Tumour suppressor gene p16(CDKN2A) mutation status and promoter inactivation in head and neck cancer. Int J Mol Med. 4:1999;61-65.
99. Reed A.L., Califano J., Cairns P., Westra W.H., Jones R.M., Koch W.etal. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 56:1996;3630-3633.
100. Lang J.C., Tobin E.J., Knobloch T.J., Schuller D.E., Bartynski K.J., Mountain R.E.etal. Frequent mutation of p16 in squamous cell carcinoma of the head and neck. Laryngoscope. 108:1998;923-928.
101. Okami K., Reed A.L., Cairns P., Koch W.M., Westra W.H., Wehage S.etal. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Oncogene. 18:1999;3541-3545.
102. Wu C.L., Roz L., McKown S., Sloan P., Read A.P., Holland S.etal. DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas. Genes, Chromosomes, Cancer. 25:1999;16-25.
103. Sartor M., Steingrimsdottir H., Elamin F., Gaken J., Warnakulasuriya S., Partridge M., Thakker N., Johnson N.W., Tavassoli M. Role of p16/MTS1, cyclin D1 and Rb in primary oral cancer and oral cancer cell lines. Br J Cancer. 80:1999;79-86.
104. Merlo A., Herman J.G., Mao L., Lee D.J., Gabrielson E., Burger P.C.etal. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine. 1:1995;686-692.
105. El-Naggar A.K., Lai S., Clayman G., Lee J.K., Luna M.A., Goepfert H., Batsakis J.G.etal. Methylation, a major mechanism of p16/C. D.K.N.2. gene inactivation in head and neck squamous carcinoma. Am J Pathol. 151:1997;1767-1774.
106. Tao J., Wu B., Fang W., Guo M., Zhong G., Heng W. Mutation and methylation of CDKN2 gene in human head and neck carcinomas. J Clin Pathol. 26:1997;152-154.
107. Patel V., Jakus J., Harris C.M., Ensley J.F., Robbins K.C., Yeudall W.A. Altered expression and activity of G1/S cyclins and cyclin-dependent kinases characterise squamous cell carcinomas of the head and neck. Int J Cancer. 73:1997;551-555.
108. Kyomoto R., Kumazawa H., Toda Y., Sakaida N., Okamura A., Iwanaga M.etal. Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer. 74:1997;576-581.
109. Liggett W.H., Sidransky D. Role of the p16 tumour suppressor gene in cancer. J Clin Oncol. 16:1998;1197-1206.
110. Sandig V., Brand K., Herwig S., Lukas J., Bartek J., Strauss M.etal Adenovirally transferred p16 and p53 genes cooperate to induce apoptotic tumour cell death. Nature Med. 3:1997;313-319.
111. Gasparotto D., Vukosavljevic T., Piccinin S., Barzan L., Sulfaro S., Armellin M.etal. Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis. Int J Cancer. 84:1999;432-436.
112. Henderson YC, Wang E, Clayman GL. Genotypic analysis of tumor suppressor genes PTEN/MMAC1 and p53 in head and neck squamous cell carcinomas. Laryngoscope 1998;108(10):1553-6.
113. Steck PA, Pershouse MA, Jasser SA, Yung WK. Lin H, Ligon AH, et al. Identification, of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15(4):356-62.
114. Okami K., Wu L., Riggins G., Cairns P., Goggoins M., Evron E.etal. Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors. Cancer Res. 58:1998;509-511.
115. Chen Q., Samaranayake L.P., Zhou H., Xiao L. Homozygous deletion of the PTEN tumor suppressor gene is not a feature in oral squamous cell carcinoma. Oral Oncology. 36:1999;95-99.
116. Zaslav A.L., Stamberg J., Steinberg G.M., Lin Y.J., Abramson A. Cytogenetic analysis of head and neck carcinomas. Cancer Genet Cytogenet. 56:1991;181-187.
117. Lese C.M., Rossie K.M., Appel B.M.N., Reddy J.K., Johnson J.T., Myers E.N.etal. Visualisation of Int2 and Hst1 amplification in oral squamous cell carcinomas. Genes, Chromosomes and Cancer. 12:1995;288-295.
118. Bartkova J., Lukas J., Muller H., Strauss M., Gusterson B., Bartek J.etal. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res. 55:1995;949-956.
119. Michalides R., van Veelen N., Hart A., Loftus B., Wientjens E., Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res. 55:1995;975-978.
120. Lovec H., Sewing A., Lucibello F.C., Muller R., Moroy T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras. link between cell cycle control and malignant transformation Oncogene. 9:1994;323-326.
121. Kotelnikov V.M., Coon J.S., Mundle S., Kelanic S., LaFollette S., Taylor S.etal. Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin Cancer Res. 3:1997;95-101.
122. Jin Y., Hoglund M., Jin C., Martins C., Wennerberg J., Akervall J.etal. FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q. Genes, Chromosomes, Cancer. 22:1998;312-320.
123. Staibano S., Mignogna M.D., LoMuzio L., DiAlberti L., DiNatale E., Lucariello A.etal. Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity. Hum Pathol. 29:1998;1189-1194.
124. Xu J., Gimenez-Conti I.B., Cunningham J.E., Collet A.M., Luna M.A., Lanfranchi H.E.etal. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer. 83:1998;204-212.
125. Kuo M.Y.P., Lin C.Y., Hahn L.J., Cheng S.J., Chiang C.P. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan. J Oral Pathol Med. 28:1999;165-169.
126. Mertens F., Johansson B., Hoglund M., Mitelman F. Chromosomal imbalance maps of malignant solid tumour; a cytogenetic survey of 3,185 neoplasms. Cancer Res. 57:1997;2765-2780.
127. Fortin A., Guerry M., Guerry R., Talbot M., Parise O., Schwaab G.etal. Chromosome 11q13 gene amplification in oral and oropharyngeal carcinomas; no correlation with subclinical lymph node invasion and disease recurrence. Clin Cancer Res. 3:1997;1609-1614.
128. Uzawa K., Suzuki H., Komiya A., Nakanishi H., Ogawara K., Tanzawa H.etal. Evidence for two distinct tumor-suppressor gene loci on the long arm of chromosome 11 in human oral cancer. Int J Cancer. 67:1996;510-514.
129. Volling P., Jungejulsing M., Jucker M., Stutzer H., Diehl V., Tesch H. Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck. Eur J Cancer. 29A:1993;383-389.
130. Lucas J.M., Mountain R.E., Gramza A.W., Schuller D.E., Wilkie N.M., Lang J.C. Expression of cyclin D1 in squamous cell carcinomas of the head and neck. International Journal of Oncology. 5:1994;469-472.
131. Zhou D.J., Casey G., Cline M.J. Amplification of human Int-2 in breast cancers and squamous carcinomas. Oncogene. 2:1988;279-282.
132. Sheng Z.M., Barrois M., Klijanienko J., Micheau C., Richard J.M., Riou G. Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas. Br J Cancer. 62:1990;398-404.
133. Saranath D., Bhoite L.T., Mehta A.R., Sanghavi V., Deo M.G. Loss of allelic heterozygosity at the harvey ras locus in human oral carcinomas. J. Cancer Res Clin Oncol. 117:1991;484-488.
134. Kiaris H., Spandidos D.A., Jones A.S., Field J.K. Loss of heterozygosity and microsatellite instability of the H-ras gene in cancer of the head and neck. International Journal of Oncology. 5:1994;579-582.
135. Saranath D., Panchal R.G., Nair R., Mehta A.R., Sanghavi V., Sumegi J.etal. Oncogene amplification in squamous cell carcinoma of the oral cavity. Jpn J Cancer Res. 80:1989;430-437.
136. Das N., Majumder J., DasGupta U.B. Ras gene mutations in oral cancer in eastern India. Oral Oncology. 36:1999;76-80.
137. McDonald J.S., Jones H., Pavelic Z.P., Pavelic L.J., Stambrook P.J., Gluckman J.L. Immunohistochemical detection of the H-ras, K-ras, and N-ras oncogenes in squamous cell carcinoma of the head and neck. J Oral Pathol Med. 23:1994;342-346.
138. Field J.K., Malliri A., Jones A.J., Spandidos D.A. Mutations in the p53 gene at codon 249 are rare in squamous cell carcinoma of the head and neck. Int J Oncol. 1:1992;253-256.
139. Chang S.E., Bhatia P., Johnson N.W., Morgan P.R., McCormick F., Young B.etal. Ras mutations in United Kingdom examples of oral malignancies are infrequent. Int J Cancer. 48:1991;409-412.
140. Warnakulasuriya K.A.A.S., Chang S.E., Johnson N.W. Point mutations in Ha-ras oncogene are detectable in formalin-fixed tissues of oral squamous cell carcinomas, but are infrequent in British cases. J Oral Pathol Med. 21:1992;225-229.
141. Clark L.J., Edington K., Swan I.R.C., McLay K.A., Newlands W.J., Wills L.C.etal. The absence of Harvey ras mutations during development and progression of squamous cell carcinomas of the head and neck. Brit J Cancer. 68:1993;617-620.
142. Yeudall W.A., Torrance L.K., Elsegood K.A., Speight P., Scully C., Prime S.S. Ras gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions. Oral Oncol Eur J Cancer. 29B:1993;63-67.
143. Kannan S., Balaram P., Radhakrishna Pillai, Chandran G.J., Nair M.K. Immunohistochemical analysis of ras p21 expression in normal, premalignant and malignant oral mucosa. Int J Cancer. 55:1993;700-702.
144. Anderson J.A., Irish J.C., McLachlin C.M., Ngan B.Y. H-ras oncogene mutation and human papillomavirus infection in oral carcinomas. Arch Otolaryngol Head Neck Surg. 120:1994;755-760.
145. Steenbergen R.D.M., Hermsen M.A.J.A., Walboomers J.M.M., Joenje H., Arwert F., Meijer C.J.L.M.etal. Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res. 55:1995;5465-5471.
146. Kuo M.Y.P., Jeng J.H., Chiang C.P., Hahn L.J. Mutations of Ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan. J Oral Pathol Med. 23:1994;70-74.
147. El-Naggar A.K., Lai S., Tucker S.A., Clayman G.L., Goepfert H., Hong W.K.etal. Frequent loss of imprinting of the IGF2 and H19 genes in head and neck squamous carcinoma. Oncogene. 18:1999;7063-7069.
148. Jordan R.C.K., Bradley G., Slingerland J. Reduced levels of the cell-cycle inhibitor p27 in epithelial dysplasia and carcinoma of the oral cavity. Am J Pathol. 152:1998;585-590.
149. Kudo Y., Takata T., Yasui W., Ogawa I., Miyauchi M., Takekoshi T.etal. Reduced expression of cyclin-dependent kinase inhibitor p27 is an indicator of malignant behavior in oral squamous cell carcinoma. Cancer. 83:1998;2447-2455.
150. Fujieda S., Inuzuka M., Tanaka N., Sunaga H., Fan G.K., Ito T.etal. Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma. Int J Cancer. 84:1999;315-320.
151. Mineta H., Miura K., Suzuki I., Takebayashi S., Amano H., Araki K.etal. Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. Cancer. 85:1999;1011-1017.
152. Venkatesan T.K., Kuropkat C., Caldarelli D.D., Panje W.R., Hutchinson J.C., Chen S.etal. Prognostic significance of p27 expression on carcinoma of the oral cavity and oropharynx. Laryngoscope. 109:1999;1329-1333.
153. Tsuji T., Duh F.M., Latif F., Popescu N.C., Zimonjic D.B., McBride J.etal. Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene Doc-1. J Biol Chem. 273:1998;6704-6709.
154. Yoo G.H., Xu H.J., Brennan J.A., Westra W., Hruban R.H., Koch W.etal. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Research. 54:1994;4603-4606.
155. Maestro R., Piccinin S., Doglioni C., Gasparotto D., Vukosavljevic T., Sulfaro S.etal. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas. identification of two distinct regions of preferential loss Cancer Res. 56:1996;1146-1150.
156. Gupta V.K., Schmidt A.P., Pashia M.E., Sunwoo J.B., Scholnick S.B. Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma. Int J Cancer. 84:1999;453-457.
157. Ogawara K., Miyakawa A., Shiiba M., Uzawa K., Watanabe T., Wang X.L.etal. Allelic loss of chromosome 13q14. 3 in human oral cancer;correlation with lymph node metastasis. Int J Cancer. 79:1998;312-317.
158. El-Naggar A.K., Lai S., Clayman G., Zhou J.H., Tucker S.A., Myers J.etal Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinomas; biological, and clinical implications. Hum Pathol. 30:1999;1013-1018.
159. Regezi J.A., Dekker N.P., McMillan A., Ramirez-Amador V., Meneses-Garcia A.etal. Ruiz-Godoy, P53 p21, Rb, and MDM2 proteins in tongue carcinoma from patients <35 versus >75 years. Oral, Oncology. 35:1999;379-383.
160. Nawroz-Danish H.M., Koch W.M., Westra W.H., Yoo G., Sidransky D. Lack of BRCA2 alterations in primary head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 119:1998;21-25.
161. Hamel N., Manning A., Black M.J., Tonin P.N., Foulkes W.D. An absence of founder BRCA2 mutations in individuals with squamous cell carcinoma of the head and neck. Int J Cancer. 83:1999;803-804.
162. Owens W., Field J.K., Howard P.J., Stell P.M. Multiple cytogenetic aberrations in squamous cell carcinomas of the head and neck. Oral Oncol Eur J Cancer. 28B:1992;17-21.
163. Saito Y., Takazawa H., Uzawa K., Tanzawa H., Sato K. Reduced expression of E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 5′ CpG island. Int J Oncol. 12:1998;293-298.
164. Chang F., Syrjanen S., Syrjanen K. Implications of the p53 tumour suppressor gene in clinical oncology. J Clin Oncol. 13:1995;1009-1022.
165. Field J.K., Pavelic Z.P., Spandidos D.A., Stambrook P.J., Jones A.S., Gluckman J.L. The role of the p53 tumour suppressor gene in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 119:1993;1118-1122.
166. Raybaud-Diogene H., Tetu B., Morency R., Fortin A., Monteil R.A. P53 overexpression in head and neck squamous cell carcinoma. review of the literature Oral Oncol Eur J Cancer. 32B:1996;143-149.
167. Calzolari A., Chiarelli I., Bianchi S., Messerini L., Gallo O., Porfirio B.etal. Immunohistochemical vs molecular biology methods; complementary techniques for effective screening of p53 alterations in head and neck cancer. Am J Clin Pathol. 107:1997;7-11.
168. Van Heerden W.F.P., Van Rensburg E.J., Hemmer J., Raubenheimer E.J., Engelbrecht S. Correlation between p53 gene mutation, p53 protein labeling and PCNA expression in oral squamous cell carcinomas. Anticancer Res. 18:1998;237-240.
169. Taylor D., Koch W.M., Zahurak M., Shah K., Sidransky D., Westra W.H. Immunohistochemical detection of p53 protein accumulation in head and neck cancer; correlation with p53 gene alterations. Hum Pathol. 30:1999;1221-1225.
170. Burns J.E., Baird M.C., Clark L.J., Burns P.A., Edington K., Chapman C.etal. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer. 67:1993;1274-1284.
171. Chen Y.T., Xu L., Massey L., Zlotolow I.M., Huvos A.G., Garin-Chesa P.etal. Frameshift and nonense p53 mutations in squamous cell carcinoma of head and neck: non-reactivity with three anti-p53 monoclonal antibodies. International Journal of Oncology. 4:1994;609-614.
172. Ranasinghe A.W., Warnakulasuriya K.A.A.S., Johnson N.W. Low prevalence of expression of p53 oncoprotein in oral carcinomas from Sri Lanka associated with betel and tobacco chewing. Oral Oncol Eur J Cancer. 29B:1993;147-150.
173. Xu L., Chen Y.T., Huvos A.G., Zlotolow I.M., Rettig W.J., Old L.J.etal. Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations. Diagnostic Molecular Pathology. 3:1994;83-92.
174. Dowell S.P., Ogden G.R. The use of antigen retrieval for immunohistochemical detection of p53 over-expression in malignant and benign oral mucosa. a cautionary tale J Oral Pathol Med. 25:1996;60-64.
175. Partridge M., Kiguwa S., Emilion G., Pateromichelakis S., A'Hern R., Langdon J. New insights into p53 protein stabilisation in oral squamous cell carcinoma. Oral Oncology. 35:1999;45-55.
176. Nunn J., Scholes A.G., Liloglou T., Nagini S., Jones A.S., Vaughan E.D.etal. Fractional allele loss indicates distinct genetic populations in the development of squamous cell carcinoma of the head and neck (SCCHN). Carcinogenesis. 12:1999;2219-2228.
177. Field J.K., Spandidos D.A., Malliri A., Yiagnisis M., Gosney J.R., Stell P.M. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer. 64:1991;573-577.
178. Brachman D.G., Graves D., Vokes E., Beckett M., Haraf D., Montag A.etal. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res. 52:1992;4832-4836.
179. Langdon J.D., Partridge M. Expression of the tumour suppressor gene p53 in oral cancer. Br J Oral Maxillofac Surg. 30:1992;214-220.
180. Ogden G.R., Kiddie R.A., Lunny D.P., Lane D.P. Assessment of p53 protein expression in normal benign and malignant oral mucosa. J Pathol. 166:1992;389-394.
181. Chang Y., Lin Y., Tsai C., Shu C., Tsai M., Choo K.etal. Detection of mutations in p53 gene in human head and neck carcinomas by single strand conformation polymorphism analysis. Cancer Lett. 67:1992;167-174.
182. Warnakulasuriya K.A.A.S., Johnson N.W. Expression of the tumour suppressor gene p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med. 21:1992;404-408.
183. Matthews J.B., Scully C., Jovanovic A., Van der Waal I., Yeudall W.A., Prime S.S. Relationship of tobacco/alcohol use to p53 expression in patients with lingual squamous cell carcinomas. Oral Oncol Eur J Cancer. 29B:1993;285-289.
184. Matsumura T., Yoshihama Y., Kimura T., Shintani S., Alcalde R.E. p53 and MDM2 expression in oral squamous cell carcinoma. Oncology. 53:1996;308-312.
185. Munijaran A.K., Tutsumi-Ishii Y., Hohanprasad B.K.C., Hirano Y., Munakata N., Shanmugan G.etal. p53 gene mutations in oral carcinomas from India. Int J Cancer. 36:1996;297-300.
186. Yan J.J., Tzeng C.C., Jin Y.T. Overexpression of p53 protein in squamous cell carcinoma of buccal mucosa and tongue in Taiwan. an immunohistochemical and clinicopathological study J Oral Pathol Med. 25:1996;55-59.
187. Steingrimsdottir H., Penhallow J., Farzaneh F., Johnson N., Tavassoli M. Detection of p53 mutations in oral cancer samples using a sensitive PCR-based method. Trans Biochem Soc. 25:1997;1997-1999.
188. Nagai M.A., Miracca E.C., Yamamoto L., Moura R.P., Simpson A.J.G., Kowalski L.P.etal. TP53 genetic alterations in head-and-neck carcinomas from Brazil. Int J Cancer. 76:1998;13-18.
189. Kannan K., Munirajan A.K., Krishnamurthy J., Bhuvarahamurthy V., Mohanprasad B.K.C., Panishankar K.H.etal. Low incidence of p53 mutations in betel quid and tobacco chewing-associated oral squamous cell carcinoma from India. Int J Oncol. 15:1999;1133-1136.
190. Gusterson B.A., Anbazaghan R., Warren W., Midegely C., Lane D.P., O'Hare M.etal. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene. 6:1991;1785-1789.
191. Caamano J., Zhang S.Y., Rosvold E.A., Bauer B., Klein-Szanto A.J.P. p53 alterations in human squamous cell carcinomas and carcinoma cell lines. American Journal of Pathology. 142:1993;1131-1139.
192. Adamson R., Jones A.S., Field J.K. Loss of heterozygosity studies on chromosome 17 in head and neck cancer using microsatellite markers. Oncogene. 9:1994;2077-2092.
193. Boyle J.O., Hakim J., Koch W., van der Riet P., Hruban R.H., Roa R.A.etal. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Research. 53:1993;4477-4480.
194. Shin D.M., Kim J., Ro J.Y., Hittelman J., Roth J.A., Hong W.K.etal. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 54:1994;321-326.
195. Kaur J., Srivastava A., Ralhan R. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous cell carcinoma in India. Int J Cancer. 58:1994;240-245.
196. Slootweg P.J., Koole R., Hordijk G.J. The, presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Oral Oncol Eur J Cancer. 30B:1994;138-141.
197. Wood M.W., Medina J.E., Thompson G.C., Houck J.R., Min K-W. Accumulation of the p53 tumour-suppressor gene product in oral leukoplakia. Otolaryngol Head Neck Surg. 111:1994;758-763.
198. Shintani S., Yoshihama Y., Emilio A.R., Matsumura T. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas. Anticancer Res. 15:1995;205-208.
199. Kusama K., Okutsu S., Takeda A. P53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma. J Pathol. 178:1996;415-421.
200. Warnakulasuriya K.A.A.S., Johnson N.W. Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma. J Oral Pathol Med. 23:1994;246-250.
201. Nees M., Homann N., Discher H., Andl T., Enders C., Harrold-Mende C.etal. Expression of mutated p53 occurs in tumour-distant epithelia of head and neck cancer patients. a possible molecular basis for the development of multiple tumors Cancer Res. 53:1993;4189-4196.
202. Lazarus P., Garewal H.S., Sciubba J., Zwiebel N., Calcagnotto A., Air A.etal. A low incidence of p53 mutations in premalignant lesions of the oral cavity from non-tobacco users. Int J Cancer. 60:1995;458-463.
203. Regezi J.A., Zarbo R.J., Regev E., Pisanty S., Silverman S., Gazit D. p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas. J Oral Pathol Med. 24:1995;18-22.
204. Kaur J., Srivastava A., Ralhan R. Prognostic significance of p53 protein over-expression in betel and tobacco related oral oncogenesis. Int J Cancer. 79:1998;370-375.
205. Cruz I.B., Snijders P.J.F., Meijer C.J., Braakhuis B.J., Snow G.B., Walboomers J.M.etal. P53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol. 184:1998;360-368.
206. Qin G.Z., Park J.Y., Chen S.Y., Lazarus P. A high prevalence of p53 mutations in premalignant oral erythroplakia. Int J Cancer. 80:1999;345-348.
207. Saranath D., Tandle A.T., Teni T.R., Dedhia P.M., Borges A.M., Parikh D.etal. P53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India. Oral Oncology. 35:1999;242-250.
208. Van Oijen M.G.C.T., Van de Craats J.G., Slootweg P.J. P53 overexpression in oral mucosa in relation to smoking. J Pathol. 187:1999;469-474.
209. Waridel F., Estreicher A., Bron L., Flaman J.M., Fontolliet C., Monnier P.etal. Field cancerisation and polyclonal p53 mutation in the upper areodigestive tract. Oncogene. 14:1997;163-169.
210. Lazarus P., Sheikh S.N., Ren Q., Schantz S.P., Stern J.C., Richie J.P.etal. P53 but not p16 mutations in oral squamous cell carcinomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and tobacco use. Carcinogenesis. 19:1998;509-514.
211. Agarwal S., Mathur M., Srivastava A., Ralhan R. MDM2/p53 co-expression in oral premalignant and malignant lesions; potential prognostic implications. Oral Oncology. 35:1999;209-216.
212. Chung K.Y., Mukhopadyay T., Kim J., Casson A., Ro J.Y., Goepfert H.etal. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Research. 53:1993;1676-1683.
213. Zariwala M., Schmid S., Pfaltz M., Ohgaki H., Kleihues P., Schafer R. p53 gene mutations in oropharyngeal carcinomas. a comparison of solitary and multiple primary tumours and lymph-node metastases Int J Cancer. 56:1994;807-811.
214. Fogel S., Ahomadegbe J.C., Barrois M., Le Bilhan M.L., Douc-Rosy S., Duvillard P.etal. Incidence elevee des mutations p53 dans les tumeurs primitives et metastases des voies aerodigestives superieures et frequente en proteine dans les epitheliums normaux. Bull Cancer. 83:1996;227-233.
215. Gasparotto D., Maestro R., Barzan L., Vukosavljevic T., Doglioni C., Sulfaro S.etal. Recurrences and second primary tumours in the head and neck region. differentiation by p53 mutation analysis Ann Oncol. 6:1995;933-939.
216. Koch W.M., Boyle J.O., Mao L., Hakim J., Hruban R.H., Sidransky D. p53 gene mutations as markers of tumour spread in synchronous oral cancers. Arch Otolaryngol Head Neck Surg. 120:1994;943-947.
217. Kropveld A., Van Mansfeld A.D.M., Nabben N., Jordijk G.J., Slootweg P.J.etal. Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients. Oral Oncol. 6:1996;388-393.
218. Gallo O., Sardi I., Pepe G., Franchi A., Attanasio M., Giusti B.etal. Multiple primary tumors of the upper aerodigestive tract; is there a role for constitutional mutations in the p53 gene? Int J Cancer. 82:1999;180-186.
219. Field J.K., Spandidos D.A., Stell P.M. Overexpression, of the p53 gene in head and neck cancer, linked with heavy smoking and drinking. Lancet. 339:1992;502-503.
220. Field J.K., Zoumpourlis V., Spandidos D.A., Jones A.S. P53 expression and mutations in squamous cell carcinoma of the head and neck. expression correlates with the patients use of tobacco and alcohol Cancer Detect Prev. 18:1994;197-208.
221. Lazarus P., Stern J., Zwiebel N., Fair A., Richie J.P. Jr., Schantz S. Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use. Carcinogenesis. 17:1996;733-739.
222. Brennan J.A., Boyle J.O., Koch W.M., Goodman S.N., Hruban R.H., Eby Y.J.etal. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. New Engl J Med. 332:1995;712-717.
223. Hogmo A., Munck-Wikland E., Kuylenstierna R., Lindholm J., Auer G. Nuclear DNA content and p53 immunostaining in oral squamous cell carcinoma - an analysis of a consecutive 10 year material. Int J Oncol. 5:1994;915-920.
224. Nakanishi Y., Noguchi M., Matsuno Y., Saikawa M., Mukai K., Shimosato Y.etal. p53 expression in multicentric squamous cell carcinoma and surrounding squamous epithelium of the upper aerodigestive tract. Cancer. 75:1995;1657-1662.
225. Franceschi S., Gloghini A., Maestro R., Barzan L., Bidoli E., Talamini R.etal. Analysis of the p53 gene in relation to tobacco and alcohol in cancers of the upper aero-digestive tract. Int J Cancer. 60:1995;872-876.
226. Liloglou T., Scholes A.G.M., Spandidos D.A., Vaughan E.D., Jones A.S., Field J.K. P53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability. Cancer Res. 57:1997;4070-4074.
227. Koch W.M., Patel H., Brennan J., Boyle J.O., Sidransky D. Squamous cell carcinoma of the head and neck in the elderly. Arch Otolaryngol Head Neck Surg. 121:1995;262-265.
228. Sorensen D.M., Lewark T.M., Haney J.L., Meyers A.D., Krause G., Franklin W.A. Absence of p53 mutations in squamous carcinoas of the tongue in nonsmoking and nondrinking paitients younger than 40 years. Arch Otolaryngol Head Neck Surg. 123:1997;503-506.
229. Colucci S., El-Gehani R., Flint S., Mothersill C. p53 mutations and potein expression in primary cutures of normal oral mucosa in smokers and non-smokers. Oral Oncol. 33:1997;240-246.
230. Mutirangura A., Supiyaphun P., Trirekapan S., Sriuranpong V., Sakuntabhai A., Yenrudi S.etal. Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Cancer Res. 56:1996;3530-3533.
231. Wong Y.K., Liu T.Y., Chang K.W., Lin S.C., Chao T.W., Li P.L.etal. P53 alterations in betel quid and tobacco associated oral suqamous cell carcinomas from Taiwan. J Oral Pathol Med. 27:1998;243-248.
232. Thomas S., Brennan J., Martel G., Frazer I., Montesano R., Sidransky D.etal. Mutations, in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea. Cancer Research. 54:1994;3588-3593.
233. Baral R.N., Patnaik S., Das B.R. Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel and tobacco-related oral squamous cell carcinomas from eastern India. Eur J Oral Sci. 106:1998;907-913.
234. Chiba I., Muthumala M., Yamazaki Y., Zaman A.U., Iizuka T., Amamiya A.etal. Characteristics of mutations in the p53 gene of oral squamous-cell carcinomas associated with betel-quid chewing in Sri Lanka. Int J Cancer. 77:1998;839-842.
235. Kaur J., Srivastava A., Ralhan R. p53-HSP70 complexes in oral dysplasia and cancer; potential prognostic implications. Oral Oncol. 32:1996;45-49.
236. Trivedy C., Warnakulasuriya K.A.A.S., Tavassoli M., Steingrimsdottir H., Penhallow J., Maher R.etal. p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP. J Oral Pathol Med. 27:1998;72-77.
237. Ibrahim S.O., Vasstrand E.N., Johannessen A.C., Idris A.M., Magnusson B., Nilsen R.et al.Mutations of the p53 gene in oral squamous cell carcinomas from Sudanese dippers of nitrosamine-rich Toombak and non-snuff-dippers from the Sudan and Scandinavia Int J Cancer. 81:1999;527-534.
238. Kriek E., Engelse L.D., Scherer E., Westra J.G. Formation of DNA modifications by chemical carcinogens, identification, localization and quantification. Biochem Biophys Acta. 738:1984;181-201.
239. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumour suppressor gene. clues to cancer etiology and molecular pathogenesis Cancer Research. 54:1994;4855-4878.
240. Olshan A.F., Weissler M.C., Pei H., Conway K. p53 mutations in head and neck cancer; new data and evaluation of mutational spectra. Cancer Epidemiol. 6:1997;499-504.
241. Sakai E., Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumour-suppressor genes. Oncogene. 7:1992;927-933.
242. Somers K.D., Merrick M.A., Lopez M.E., Incofnito L.S., Schechter G.L., Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res. 52:1992;5997-6000.
243. Nylander K., Schildt E.B., Eriksson M., Magnusson A., Mehle C., Roos G. A non-random deletion in the p53 gene in oral squamous cell carcinoma. Brit J Cancer. 73:1996;1381-1386.
244. Lee N.K., Ye Y.-W., Chen J., Li X., Waber P.G., Nisen P.D. p53 retinoblastoma and human papillomavirus in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg. 119:1991;1125-1131.
245. Mietz J.A., Unger T., Hubregtse J.M., Howley P.M. The transcriptional function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. Embo J. 11:1992;5013-5020.
246. Hubbert N.L., Sedman S.A., Schiller J.T. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. J Virol. 66:1992;6237-6241.
247. Momand J., Zambetti G.P., Olson D.C., George D., Levine A.J. The mdm-2 oncogene product froms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 69:1992;1237-1245.
248. WAF1/CIP1, gadd45, cyclins, cyclin-dependent kinases and PCNA in oral cancer Int J Oncol. 8:1996;21-28.
249. Kessis T.D., Slebos R.J., Nelson W.G.etal Human papillomavirus 16 EB expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA. 90:1993;3988-3992.
250. Snijders P.J.F., van den Brule A.J.C., Meijer C.J.L.M., Walboomers J.M.M. Papillomaviruses and cancer of the upper digestive and respiratory tracts. Curr Topics Microbiol Immunol. 186:1994;177-198.
251. Snijders P.J.F., Scholes A.G.M., Hart C.A., Jones A.S., Vaughan E.D., Woolgar J.A.etal Prevalence of mucosotropic human papillomaviruses in squamous cell carcinomas of the head and neck. Int J Cancer. 66:1996;1-6.
252. Lewensohn-Fuchs I., Munck-Wikland E., Berke Z., Magnusson K.P., Pallesen G., Auer G.etal. Involvement of aberrant p53 expression and human papillomavirus in carcinoma of the head, neck and esophagus. Anticancer Res. 14:1994;1281-1286.
253. Scholes A.J., Woolgar J.A., Boyle M.A., Brown J.S., Vaughan E.D., Hart C.Aetal. Synchronous oral carcinomas: independent or common clonal origin? Cancer Res. 58:1998;2003-2006.
254. Mao E.-J., Schwartz S.M., Daling J.R., Oda D., Tickman L., Beckmann A.M. Human papilloma viruses and p53 mutations in normal premalignant and malignant oral epithelia. Int J Cancer. 69:1996;152-158.
255. Chiba I., Shindoh M., Yasuda M., Yamazak Y., Amemiya A., Sao Y.etal. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene. 12:1996;1663-1668.
256. Wang Q., Lasset C., Sobol H., Ozturk M. Evidence of a hereditary p53 syndrome in cancer-prone families. Int J Cancer. 65:1996;554-557.
257. Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ et al. Germ-line, mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 1997 Aug 1;57(15):3245-52.
258. Ibrahim S.O., Vasstrand E.N., Liavaag P.G., Johannessen A.C., Lillehaug J.R. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck. Anticancer Res. 17:1997;4539-4546.
259. Stevens H.P., Kessell D.P., Bryant S.P., Spurr N.K., Weissenbach J., Marger R.S.et al. Palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type 111) in an extensive North American pedigree is linked to TOCG locus (17q24) and shows a characteristic clinical phenotype. Arch Dermatol. 132:1996;640-651.
260. LoMuzio L., Mignogna M.D., Pannone G., Staibano S., Procaccini M., Serpico R.etal. The NM23 gene and its expression in oral squamous cell carcinoma. Oncology Reports. 6:1999;747-751.
261. Jones J.W., Raval J.R., Beals T.F., Worsham M.J, Van Dyke D.L., Escalamado R.M.etal. Frequent loss of heterozygosity on chromosome arm 18q in squamous cell carcinomas. Arch Otolaryngol Head Neck Surg. 123:1997;610-614.
262. Watanabe T., Wang X.L., Miyakawa A., Shiiba M., Imai Y., Sato T.etal. Mutational state of tumour suppressor genes (DCC, DPC4) and alteration on chromosome 18q21 in human oral cancer. Int J Oncol. 11:1997;1287-1290.
263. Cowan J.M., Beckett M.A., Ahmed-Swan S., Weichselbaum R.R. Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas. J Natl Cancer Inst. 84:1992;793-797.
264. Rowley H., Jones A.S., Field J.K. Chromosome 18. a possible site for a tumour suppressor gene deletion in squamous cell carcinoma of the head and neck Clin Otol. 20:1995;266-271.
265. Kim S.K., Fan Y., Papadimitrakopoulou V., Clayman G., Hittleman W.N., Hong W.K.etal. DPC4, a candidate tumour suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res. 56:1996;2519-2521.
266. Birchall M.A., Schock E., Harmon B.V., Gobe G. Apoptosis, mitosis, PCNA and bcl-2 in normal, leukoplakic and malignant epithelia of the human oral cavity. prospective, in vivo study Oral Oncology. 33:1997;419-425.
267. Loro L.L., Vintermyr O.K., Liavaag P.G., Jonsson R., Johannessen A.C. Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis. Hum Pathol. 30:1999;1097-1105.
268. Ito T., Fujieda S., Tsuzuki H., Sunaga H., Fan G., Sugimoto C.etal. Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma. Cancer Lett. 140:1999;81-91.
269. Kannan K., Latha L., Shanmugam G. Expression of bcl-2 oncoprotein in Indian oral squamous cell carcinomas. Oral Oncology. 34:1998;373-377.
270. Schoelch M.L., Le Q.T., Silverman S., McMillan A., Dekker N.P., Fu K.K.etal. Apoptosis-associated proteins and the development of oral squamous cell carcinoma. Oral Oncol. 35:1999;77-85.
271. Yamamoto N., Uzawa K., Miya T., Watanabe T., Yokoe H., Shibahara T.etal. Frequent allellic loss/imbalance on the long arm of chromosome 21 in oral cancer; evidence for three discrete tumour suppressor gene loci. Oncol Rep. 6:1999;1223-1227.
272. Miyakawa A., Wang X.L., Nakanishi H., Imai F.L., Shiiba M., Miya T.etal. Allelic loss on chromsome 22 in oral cancer; possibility of the existence of a tumour suppressor gene on 22q13. Int J Oncol. 13:1998;705-709.
273. Sumida T., Hamakawa H., Sogawa K., Sugita A., Tanioka H., Ueda N. Telomerase components as a diagnostic tool in human oral lesions. Int J Cancer. 80:1999;1-4.
274. Mao L., El-Naggar A.K., Fan Y.H., Lee J.S., Lippman S.M., Kayser S.etal. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res. 56:1996;5600-5604.
275. Shay J.W., Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer. 33:1997;787-791.
276. Chang L.Y., Lin S.C., Chang C.S., Wong Y.K., Hu Y.C., Chang K.W. Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis. J Oral Pathol Med. 28:1999;389-396.
277. Moroco J.R., Solt D.B., Polverini P.J. Sequential loss of suppressor genes for three specific functions during in vivo carcinogenesis. Lab Invest. 63:1990;298-306.
278. Suzui M., Yoshimi N., Tanaka T., Mori H. Infrequent Ha-ras mutations and absence of Ki-ras, N-ras and p53 mutations in 4-nitroquinoline 1-oxide-induced rat oral lesions. Molecular Carcinogenesis. 14:1995;294-298.
279. Shintani S., Matsumura T., Alcalde R.E., Yoshihama Y. Sequential expression of myc-, ras-, oncogene products and EGF receptor during DMBA-induced tongue carcinogenesis. Int J Oncol. 8:1996;821-826.
280. Chang K.-W., Lin S.-C., Koos S., Pather K., Solt D. P53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas. Carcinogenesis. 17:1996;595-600.
281. Sidransky D. Molecular genetics of head and neck cancer. Current Opinion Oncol. 7:1995;229-233.
282. Todd R., Donoff B.R., Wong D.T.W. The molecular biology of oral carcinogenesis; toward a tumor progression model. J Oral Maxillofac Surg. 55:1997;613-623.
283. Jin Y.T., Myers J., Tsai S.T., Goepfert H., Batsakis J.G., El-Naggar A.K. Genetic alterations in oral squamous cell carcinoma of young adults. Oral Oncology. 35:1999;251-256.
284. Koch W.M., McQuone S. Clinical and molecular aspects of squamous cell carcinoma of the head and neck in the nonsmoker and nondrinker. Current Opinion Oncol. 9:1997;257-261.
285. Field J.K., Kiaris H., Risk J.M., Tsiriyotis C., Adamson R., Zoumpourlis Vetal. Allelotype of squamous cell carcinoma of the head and neck. fractional allele loss correlates with survival Br J Cancer. 72:1995;1180-1188.
286. Liloglou T., Maloney P., Xinarianos G., Fear S., Field J.K. Sensitivity and limitations of high throughput fluorescent microsatellite analysis for the detection of allelic imbalance. application in lung tumors Int J Oncol. 1:2000;5-14.
287. Boyd D. Invasion and metastasis. Cancer and Metastasis Reviews. 15:1996;77-89.
288. Shillitoe E.J., May M., Patel V., Lethanakul C., Ensley J.F., Strausberg R.L.etal. Genome-wide analysis of oral cancer - early results from the Cancer Genome Anatomy Project. Oral Oncology. 36:1999;8-16.